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Background: Multi-locus sequence typing (MLST) is a portable, broadly applicable method for classifying bacterial
isolates at an intra-species level. This methodology provides clinical and scientific investigators with a standardized
means of monitoring evolution within bacterial populations. MLST uses the DNA sequences from a set of genes
such that each unique combination of sequences defines an isolate’s sequence type. In order to reliably determine
the sequence of a typing gene, matching sequence reads for both strands of the gene must be obtained. This
study assesses the ability of both the standard, and an alternative set of, Streptococcus pneumoniae MLST primers to
completely sequence, in both directions, the required typing alleles.
Results: The results demonstrated that for five (aroE, recP, spi, xpt, ddl) of the seven S. pneumoniae typing alleles,
the standard primers were unable to obtain the complete forward and reverse sequences. This is due to the
standard primers annealing too closely to the target regions, and current sequencing technology failing to
sequence the bases that are too close to the primer. The alternative primer set described here, which includes a
combination of primers proposed by the CDC and several designed as part of this study, addresses this limitation
by annealing to highly conserved segments further from the target region. This primer set was subsequently
employed to sequence type 105 S. pneumoniae isolates collected by the Canadian Immunization Monitoring
Program ACTive (IMPACT) over a period of 18 years.
Conclusions: The inability of several of the standard S. pneumoniae MLST primers to fully sequence the required
region was consistently observed and is the result of a shift in sequencing technology occurring after the original
primers were designed. The results presented here introduce clear documentation describing this phenomenon
into the literature, and provide additional guidance, through the introduction of a widely validated set of alternative
primers, to research groups seeking to undertake S. pneumoniae MLST based studies.
Keywords: Multi-locus sequence typing, MLST, Invasive pneumococcal disease, Molecular epidemiology,
Streptococcus pneumoniae, Bacterial typingBackground
Accurate, reproducible isolate characterization data helps
epidemiologists, scientists, physicians, public health
officials, and many other professions, better monitor
and manage endemic and epidemic infectious disease
trends [1]. Historically, bacterial typing schemes have* Correspondence: jalcanta@ucalgary.ca
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unless otherwise stated.been based on immunological and electrophoretic ap-
proaches [2]. Immunological based schemes classify
strains on the specificity of antibodies raised against
antigenic bacterial components. This approach has
been widely applied in the form of capsular serotyping,
whereby the antigenic specificity of different intra-species
capsule types are used to classify the bacteria [3,4].
However, many globally significant bacterial pathogens
such as Streptococcus pneumoniae and Neisseria menin-
gitidis are readily able to incorporate environmentalal Ltd. This is an Open Access article distributed under the terms of the Creative
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genetic variation and interchange of immunogenic com-
ponents; including those on which serotyping is based
[5]. This phenomenon has been observed recently with
S. pneumoniae capsular typing following the introduc-
tion of the seven-valent pneumococcal conjugate vaccine
(PCV7) [6]. As a result of the component specificity of
immunological based typing methods, it has become
well recognized that strains possessing the same serotype
are not necessarily clonally related, nor expected to
possess the same repertoire of virulence factors. Im-
munogenic approaches are now used in more focused
ways to explore specific factors, particularly those rele-
vant to guiding vaccine evaluation and development, as
was demonstrated with a recent serotype B meningococ-
cal vaccine investigation [7].
Multi-locus enzyme electrophoresis (MLEE) is another
typing method, and is based on the relative electrophor-
etic mobility of a set of ubiquitously present bacterial
enzymes [8]. This approach is not dependent on a single
immunogenic component and as such is less influenced
by horizontal exchange or positive selection events.
However, it is complicated to perform and it is difficult
to compare the resulting electrophoretic types between
different groups [2]. Similar to the MLEE, pulse field gel
electrophoresis (PFGE) classifies individual strains based
on the gel electrophoretic mobility of bacterial compo-
nents: in this case the relative mobility of DNA frag-
ments which have been obtained through restriction
enzyme digestion [9]. PFGE has been widely used for
typing and has been considered a gold standard for some
epidemiological studies, however, there have been chal-
lenges in standardizing protocols between different research
groups [10].
Multi-locus sequence typing (MLST) is a classification
scheme whereby isolates are typed based on the nucleotide
sequences from a set of housekeeping genes that are neces-
sary for the maintenance of basic cellular functions. The
nucleotide sequences for each of these housekeeping genes
are used to define a unique bacterial sequence type [1].
Each gene is sequenced from individual strains and then
compared against existing sequences in a publically access-
ible, globally maintained database. Those submitted se-
quences matching ones already in the database are assigned
the gene type number of the sequence in the database; if a
novel sequence is submitted, the curator of the database as-
sesses the sequencing results and assigns an appropriate
gene number. While this approach does address several of
the limitations encountered by other typing methods, the
cost of sequencing can be a barrier to large scale typing
projects. Particularly, because of the potential for error in
sequencing reads the standard for determining a gene type
requires matching forward and reverse sequences. The S.
pneumoniae typing system is based on the partial sequenceof seven genes coding for the housekeeping proteins:
Shikimate dehyrogenase (aroE), glucose-6-phosphate de-
hydrogenase (gdh), glucose kinase (gki), transketolase (recP),
signal peptidase I (spi), xanthine phosphoribosyltransferase
(xpt), and D-alanine-D-alanine ligase (ddl) [11].
Some preliminary results, and information provided by
the curator of the S. pneumoniae MLST database indi-
cated that several of the provided MLST sequencing
primers were unable to obtain the full sequence required
in each direction. As a result, in cases where a novel
gene type is identified based on sequences from the
standard primers (Table 1), the investigators are required
to design new primers and re-sequence the particular
gene (Cynthia Bishop, personal communication, May,
2012). In these circumstances, investigators are required
to expend additional time and resources developing new
primers, as well as purchasing additional sequencing and
validating results. While several investigators in the
field are aware of this issue, and all sequences in the
MLST database have been correctly verified through
subsequent primer redesign and re-sequencing, this
limitation has not been specifically addressed in the
literature [12,13] (Cynthia Bishop, personal communi-
cation, May 2012).
The lack of description of this limitation in the litera-
ture is evidenced by the prevalence of recent studies
only referencing the original primers, and not providing
any discussion pertaining to the sequencing challenge
[6,14-18]. The purpose of this study is to systematically
identify the primers unable to obtain the correct se-
quence, describe an alternative set of primers, and intro-
duce documentation to the literature offering additional
guidance to groups undertaking S. pneumoniae MLST
studies. In this investigation, the effectiveness of the
standard MLST sequencing primers, and an alternate set
of primers were evaluated for their ability to completely
sequence, in both directions, the appropriate typing re-
gions of each gene.
Results
This analysis consistently observed that the forward and
reverse sequences obtained with the standard MLST
primers only completely covered the typing region for
two of the seven genes: gki and gdh. The reverse primer
for the aroE, and recP genes failed to sequence the
last 21 and 10 bases of their respective typing regions
(Figure 1A, and B). The forward spi and xpt MLST
primers do not sequence the first 6 and 17 bases of their
respective typing regions (Figure 1C and D). In the case
of ddl, the forward primer was unable to sequence the
first 8 bases (Figure 1E) and the reverse did not se-
quence the last 26 bases (Figure 1F). These observations
were consistent across all of the different isolates, both
sequencing services, and each replicate. In each of the
Table 1 Standard S. pneumoniae amplification and
sequencing primers proposed by Enright and Spratt [11]
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alignment of the primers with publically available gen-
omic sequences for S. pneumoniae identified that those
primers annealed less than 30 base pairs from the re-
quired typing region (Figure 1).
A partial set of modified MLST primers for S. pneu-
moniae were designed and introduced by the US Centers
for Disease Control (CDC) [12]. The CDC primers for
aroE, the reverse primer for recP, and the forward primer
of ddl each annealed within the coding sequence for the
gene possessing the typing region, and were able to com-
pletely cover the required sequence. However, the CDC
forward primer for recP, and both sets of spi and xpt
primers annealed to regions of genomic DNA outside of
their target gene. While these primers successfully se-
quenced the correct region, the highly plastic nature of
pneumococcal genome suggests these genes may not al-
ways be in the same region, and in this case primers that
bind outside of the gene may not always be specific to
the target region of the genome [19]. To address sequen-
cing errors potentially resulting from this phenomenon,
the recP CDC forward primer was replaced with thestandard MLST recP forward primer, as this primer
annealed within the recP gene and can correctly se-
quence the typing region. Novel primers that annealed
within the gene were also designed to replace the spi
and xpt CDC primers. Lastly, the CDC reverse primer
for ddl bound only 19 base pairs away from the typing
region, and a modified primer binding 57 base pairs
from the typing region was designed as a replacement. Ana-
lysis of the alternate primer sets (Table 2) using the same
five test isolates revealed that, each primer set that was suffi-
ciently down/upstream from the typing region was able to
correctly amplify and sequence the appropriate DNA
fragment (Figure 2). The effectiveness of the alternative
primer set was subsequently validated through sequence
typing of 105 diverse isolates collected by the Canadian
Immunization Monitoring Program ACTive (IMPACT)
surveillance network (Additional file 1: Table S1). In all
cases investigated in this study, the modified primers were
able to obtain the complete typing sequence, in both direc-
tions, for the gene/primer combinations not obtained by
the standard primers.Discussion
These results demonstrate that the current inability of
the standard sequencing primers to effectively sequence
the S. pneumoniae MLST typing regions is a result of
how close the primers anneal to the typing region of the
gene. When sequencing by Sanger chain termination ca-
pillary separation is employed, the base pairs immedi-
ately after the sequencing primer will not be clearly
sequenced [20]. This is a characteristic of the size separat-
ing technology used by chain termination sequencing.
When the terminated segments are separated based on size,
there is poor resolution between the smaller fragments at
the start of the sequence. This results in unclear and am-
biguous sequencing results for approximately the first 20 –
50 base pairs of the sequence.
Next generation sequencing approaches such as 454,
Illumina, and ABI function by determining the sequence
for overlapping segments of 35 to 200 base pairs, de-
pending on the specific method, and then assembling
these segments into the complete sequence [21]. These
next generation techniques have recently been applied to
MLST with some success, however, the assembly process
can be hindered by highly repetitive sequence in the over-
lapping sections of the sequence reads. This can poten-
tially result in inaccurate assemblies within sequence
typing regions. Additionally, the infrastructure and expert-
ise required to employ next generation sequencing tech-
nologies still limits their accessibility to many research
groups [21,22]. Given these limitations, and noting the
number of recent studies still making unaltered reference
to the standard primers, it remains valuable for researchers
Figure 1 (See legend on next page.)
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Figure 1 S. pneumoniae MLST typing regions for each of the segments not fully sequenced by the standard primers aligned with a
section of the corresponding genomic DNA. Panels (A) through (F) identify each individual gene and direction combination, for which the
complete typing region is not obtained. The black arrows depict the binding sites of the standard primers to the up or downstream genomic
DNA. The line marked boxes identify the segment that is consistently not obtained by sequencing with the standard primers. The angle bracket
and top sequence identify either the 5’ or 3’ end of the typing region depending on the specific MLST gene.
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by the standard MLST sequencing primers.Conclusion
The alternative primer set described here addresses
the limitation of the standard S. pneumoniae MLST
primers by annealing sufficiently far from the target re-
gion such that the sequence for the correct segment is
consistently obtained. Clear documentation definingTable 2 Alternate primers used for amplifying and
sequencing each of the seven genes for multi locus
sequencing typing S. pneumoniae













































1The aroE primers, the recP reverse primer, the xpt primers and the ddl forward
primer were designed by the US Centers for Disease Control [12].
2The recP forward primer, and the gdh and gki primers are the originals
developed by Spratt and Enright [11].
3The spi primers and the ddl reverse primer were designed as part of
this study.the limitations of the standard S. pneumoniae MLST
primers and describing an effective set of alternative
primers is of particular importance as automated Sanger
capillary sequencing remains a highly optimized, and still
widely employed method for S. pneumoniae MLST based
studies.
Methods
Streptococcus pneumoniae strains and genomic
preparation
Evaluation of the standard and alternative MLST primers
was carried out on five randomly selected isolates from
strains collected provided by the Canadian Immunization
Monitoring Program ACTive (IMPACT) [23-26]. Isolates
were obtained from patients aged 0 – 16 presenting
with invasive pneumococcal infection at tertiary care
centres across Canada; diagnosis was confirmed by
positive S. pneumoniae culture from normally sterile
body fluid (blood/cerebrospinal fluid). The IMPACT
surveillance study has research ethics board approval
at each participating centre to obtain demographic,
clinical and microbiologic information on all cases
without the requirement for written informed consent.
S. pneumoniae strains were verified and serotyped as
part of IMPACT’s routine surveillance protocol. The
investigation described here was undertaken using
IMPACT's 19A invasive strains, collected with ethical
approval between 1991 and 2009. Strains were grown
overnight at 5% CO2 on Columbia Blood Agar (pre-
pared according to manufacturer’s instructions, Becton
Dickinson and Company, Difco™, Sparks, Maryland,
USA) plates with Optochin Disk (used according to
manufacturer’s instructions, Sigma-Aldrich, Oakville,
Ontario, Canada) susceptibility and the presence alpha
hemolysis used for species verification. Genomic DNA
was then isolated with the QIAamp DNA Mini Kit
(used according to manufacturer instructions, Qiagen,
Toronto, Ontario, Canada).
Sequencing methodology
Each of the seven typing alleles was evaluated with both
the standard (Table 1) and alternative (Table 2) MLST
primers. PCR solutions were prepared for each primer
set consisting of: 11 μl sterile distilled water, 2.5 μl of
10× reaction buffer (5 ml 1 M KCL, 5 ml 1 M (NH4)2SO4,
5 ml 2 M Tris–HCl pH 8.8, 5 ml 200 mM MgSO4, 5 ml
10% Triton X-100, water to 50 ml), 2.5 μl of 2 mM dNTPs,
Figure 2 5’ or 3’ end of the S. pneumoniae MLST typing region that is not obtained by both the forward and reverse standard primers
aligned with the sequencing results from both the forward and reverse alternative primers. Panels (A) through (F) depict the sequencing
results of the alternative primers in relation to their corresponding typing region. The angle bracket and top sequence identify the 5’ or 3’ end of
the typing region, the middle sequence is the result from sequencing with the forward alternative primer, and the bottom sequence is the result
from sequencing with the reverse alternative primer.
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Scientific, Ottawa, Ontario, Canada) and 2 μl of genomic
DNA template at 50 – 300 ng/μl. All PCRs were performed
in a BioRad (Mississauga, Ontario, Canada) Thermocycler
with annealing temperatures specific to each primer set(Table 1 and 2). Amplification was verified by visual-
izing gene products with gel electrophoresis on a 1% eth-
idium bromide agarose gel with a voltage of 110 V for
25 minutes. Verified PCR products were purified with the
E.Z.N.A Cycle Pure Kit (used according to manufacturer’s
Adamiak et al. BMC Microbiology 2014, 14:143 Page 7 of 8
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Purified products were subsequently verified via spectro-
photometry (used according to manufacturer’s instructions
NanoDrop 1000 Spectrophotometer, Thermo Scientific,
Ottawa, Ontario, Canada). Purified samples with a con-
centration of greater than 3 ng/μl, and 260 nm/280 nm
absorbance values between 1.0 and 2.0 were accepted to
send for sequencing. Sequencing was carried out at both
Macrogen Corporation, Rockville USA, and the University
of Calgary, Calgary Canada, DNA Core Services facility.Assessing sequence coverage
The sequencing results were manually inspected for
quality with the open source program 4Peaks, and se-
quence coverage was inspected by using the Multiple Se-
quence Alignment by Fast Fourier Transform (MAFFT)
program, available through the European Bioinformatics
Server [27]. MAFFT was used to align the forward and
reverse sequence reads from each test primer set, and
isolate, along with 5 known typing regions from the
MLST database. The annealing site of each primer was
identified by BLASTing the primer’s sequence against
publically accessible S. pneumoniae genomic sequences
available through the National Center for Biotechnology
Information [28,29]. These results identified where each
primer annealed relative to the typing region, and whether
the sequencing resulting from the primer was able to con-
sistently cover the required region. This full process was
replicated twice for each primer set and each test isolate to
confirm the reproducibility of the observations.Additional file
Additional file 1: Table S1. S. pneumoniae strains sequence typed with
alternative MLST primers.Competing interests
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